Since obesity leads to endothelial dysfunction and AMPK dysregulation, AMPK activation might be an important strategy to restore vascular function in cardiometabolic alterations. The gene discussed is PRKAA2; the disease is obesity due to melanocortin 4 receptor deficiency.